Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Prime Medicine Inc shares valued at $20,000,000 were purchased by ARCH Venture Partners XII, LLC on Feb 15 ’24. At $6.25 per share, ARCH Venture Partners XII, LLC acquired 3,200,000 shares. The insider’s holdings grew to 3,200,000 shares worth approximately $18.85 million following the completion of this transaction.
Also, ARCH Venture Partners X, LLC purchased 3,200,000 shares, netting a total of over 20,000,000 in proceeds. Following the buying of shares at $6.25 each, the insider now holds 3,200,000 shares.
Before that, NELSEN ROBERT had added 3,200,000 shares to its account. In a trade valued at $20,000,000, the Director bought Prime Medicine Inc shares for $6.25 each. Upon closing the transaction, the insider’s holdings increased to 3,200,000 shares, worth approximately $18.85 million.
As published in their initiating research note from TD Cowen on April 08, 2024, Prime Medicine Inc [PRME] has been a Buy. Analysts at Wedbush started covering the stock with ‘”an Outperform”‘ outlook in a report released in early April. As of January 16, 2024, Stifel has decreased its “Buy” rating to a “Hold” for PRME. Earlier on December 08, 2023, Citigroup initiated its rating. Their recommendation was “a Neutral” for PRME stock.
Analyzing PRME Stock Performance
During the last five days, there has been a surge of approximately 1.55%. Over the course of the year, Prime Medicine Inc shares have dropped approximately -33.52%. Shares of the company reached a 52-week high of $9.77 on 02/27/24 and a 52-week low of $5.47 on 04/05/24. A 50-day SMA is recorded $7.31, while a 200-day SMA reached $9.44. Nevertheless, trading volume fell to 0.55 million shares from 0.68 million shares the previous day.
Support And Resistance Levels for Prime Medicine Inc (PRME)
According to the 24-hour chart, there is a support level at 5.77, which, if violated, would cause prices to drop to 5.66. In the upper region, resistance lies at 6.01. The next price resistance is at 6.14. RSI (Relative Strength Index) is 35.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.38, which suggests the price will decrease in the coming days. Percent R is at 80.38%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Prime Medicine Inc subject to short interest?
Stocks of Prime Medicine Inc saw a sharp rise in short interest on Mar 28, 2024 jumping by 0.7 million shares to 9.92 million. Data from Yahoo Finance shows that the short interest on Feb 29, 2024 was 9.22 million shares. A jump of 7.06% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 18.6 of the overall float, the days-to-cover ratio (short ratio) jumped to 18.6.
